Email
Mot de passe
Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

GlycoBAR

GlycoBAR_logo
5
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

Grenoble, Auvergne-Rhône-Alpes, France

Send a message

Anglais

GlycoBAR

Anglais

GlycoBAR owns a biofermentation technology allowing to produce blood group antigen sugars by using genetically modified e-coli bacteria strains at a cost that is 30 times lower than competition selling price. This is enabling a brand new field of application, including universal human blood plasma (plasma coming from any donor, that is purged from blood group antibodies and is therefore compatible with any recipient). For that purpose, GlycoBAR proposes its blood group antigen sugars...

See more

GlycoBAR owns a biofermentation technology allowing to produce blood group antigen sugars by using genetically modified e-coli bacteria strains at a cost that is 30 times lower than competition selling price. This is enabling a brand new field of application, including universal human blood plasma (plasma coming from any donor, that is purged from blood group antibodies and is therefore compatible with any recipient). For that purpose, GlycoBAR proposes its blood group antigen sugars grafted on a cellulosic support called BAR (for Blood group Antibody Remover) that is so low cost that it is proposed in a disposable format (the product is mixed with any plasma, the antibodies in this plasma are fixed by the BAR molecules which are then eliminated by filtration). GlycoBAR also owns a patent covering affinity amplification of the antibodies with the BAR molecule. 

The same technology can be applied to purge IVIG (intravenous Immunoglobulins type G) from blood group antibodies, which is currently a huge issue in the plasma fractionation industry. GlycoBAR technology is bringing a solution to an unsolved problem in this industry wchih needs to find a solution to sustain its steady growth of 10%/year of its 5B€/year business.

GlycoBAR technology is ready to be deployed and needs 1M€ to scale-up its process

Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

Seal of Excellence
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not received funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1145 Entities

Communities